All In Biotech

Free tool

FAERS Monitor: Novolin N

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 019959 or its brand name (Novolin N, Insulin Susp Isophane Recombinant Human). Reports on generic versions are filed under their own applications.

Reports

6,504

Serious

4,443

68% of reports

Hospitalization

2,320

Death reported

593

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased1,003
  • blood glucose decreased365
  • drug ineffective362
  • nausea332
  • dyspnoea281
  • diarrhoea274
  • dizziness234
  • fatigue231
  • death227
  • hypoglycaemia225
  • fall213
  • malaise208
  • headache207
  • renal failure206
  • weight decreased195

Reports by year received

View as table
YearReports
200491
2005150
2006232
2007144
2008191
2009246
2010181
2011144
2012207
2013242
2014330
2015769
2016537
2017568
2018609
2019569
2020286
2021246
2022179
2023138
2024166
2025193
202686

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,655 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood glucose decreasedSignal36524.822.48,254
blood glucose increasedSignal1,00317.316.315,446
hypoglycaemiaSignal22515.113.22,934
renal failureSignal2065.04.4663
weight decreasedSignal1952.32.0137
fallSignal2132.11.8119
dyspnoea2811.61.465
malaise2081.51.339
dizziness2341.51.342
diarrhoea2741.41.228
nausea3321.41.232
headache2071.10.91
fatigue2311.00.80
drug ineffective3620.90.85
death2270.90.76

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.